NCT02695810 - The PRE-D Trial: Effect of Dapagliflozin, Metformin and Physical Activity in Pre-diabetes | Biotech Hunter

Enrollment

120

Participants

Timeline

Start Date

February 24, 2016

Primary Completion Date

September 20, 2018

Study Completion Date

January 13, 2019

Conditions

Prediabetic StateObesity

Interventions

DRUG

Dapagliflozin

10 mg per day as monotherapy for 13 weeks

DRUG

Metformin

2 x 850 mg per day as monotherapy for 13 weeks

BEHAVIORAL

Exercise

Interval training, 5 times per week, 30 min per session

Trial Locations (1)

Steno Diabetes Center A/S, Gentofte Municipality